Anti-arrhythmics in the ICU
Rhythm drugs · Critical Care / ICU
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
ICU staples: adenosine (diagnostic/therapeutic for regular narrow SVT), amiodarone (broad-spectrum, least negatively inotropic — first-line in the compromised), beta-blockers/verapamil (rate control — never verapamil in broad-complex), digoxin (rate control in heart failure), magnesium (torsades, digoxin toxicity, refractory arrhythmia), lidocaine (VT alternative, ischaemic).
Red flags
- Verapamil in an undiagnosed broad-complex tachycardia can be fatal — treat as VT
- Digoxin toxicity is pro-arrhythmic: bidirectional VT, blocks — check level and K⁺
Management
- Unstable + tachyarrhythmia = electricity, not pharmacology (synchronised DC)
- Before drugs: fix K⁺ >4.0–4.5, Mg²⁺ >1.0, oxygenation, and remove the pro-arrhythmic causes (catecholamines, acidosis, central-line tip in RA)
- All anti-arrhythmics are also PRO-arrhythmic and negatively inotropic to a degree — one drug at a time; combining raises block/torsades risk
- New-onset AF in the septic ICU patient: rate/rhythm often returns with treating the sepsis and the K⁺/Mg²⁺ — amiodarone if compromised
- Watch QT with amiodarone/haloperidol combinations; daily ECG on infusions
Drugs & doses
Adenosine 6→12→18 mg rapid IV push (large vein, warn the patient)
Amiodarone 300 mg over 20–60 min then 900 mg/24 h — central line for infusions
Magnesium 2 g IV over 10–15 min (torsades: give even if level normal)
Metoprolol 2.5–5 mg IV titrated / esmolol infusion
Digoxin load 500 mcg IV repeated — rate control with hypotension/HF
Electricity for the unstable; electrolytes before drugs; one anti-arrhythmic at a time.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.